Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00006395Phase 4Completed
Phase 4, open-label, single-arm trial of hypericum perforatum, sponsored by National Institutes of Health. Primary endpoints: Area Under the Curve, Oral Clearance and 1 more. Started Oct 2000; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00006395.